Intestinal Permeability and Endometriosis
Public ClinicalTrials.gov record NCT03042923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this project will be to determine whether patients with a surgical diagnosis of endometriosis have impaired intestinal permeability as compared with healthy controls. This would suggest the presence of an environmentally triggered and intestinally mediated association in the etiology of endometriosis. This would be a proof of concept trial to establish whether there is in fact a relationship worthy of future research.
Study identification
- NCT ID
- NCT03042923
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 46 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2016
- Primary completion
- May 31, 2019
- Completion
- May 31, 2019
- Last update posted
- Apr 27, 2020
2016 – 2019
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Erlanger Medical Center | Chattanooga | Tennessee | 37403 | — |
| Women's Surgery Center | Chattanooga | Tennessee | 37421 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Endometriosis trials
Other public records listing Endometriosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07728695: Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain Recruiting
- NCT05069740: Endometriosis and Microvascular Dysfunction: Role of Inflammation Recruiting
- NCT06477406: Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis Recruiting
- NCT06785129: Endometriosis and Migraine Recruiting
- NCT07679074: CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life Recruiting
- NCT07664956: Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03042923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2020 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03042923 live on ClinicalTrials.gov.